Utility of circulating tumor DNA in monitoring treatment response to immune checkpoint inhibitors in patients with advanced genitourinary cancers.

被引：0

作者：

Jang, Albert

Jaeger, Ellen B.

Rauterkus, Grant

Lieberman, Alexandra

Huang, Minqi

Lanka, Sree M.

Sudhaman, Sumedha

Mahmood, Tamara

Pajak, Natalia

Calhoun, Mark

Tlemcani, Kaoutar

ElNaggar, Adam

Liu, Minetta

Lewis, Brian E.

Layton, Jodi Lyn

Sartor, A. Oliver

Barata, Pedro C.

机构：

[1] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA

[2] Tulane Univ, New Orleans, LA 70118 USA

[3] Tulane Canc Ctr, New Orleans, LA USA

[4] Natera Inc, Austin, TX USA

[5] Natera Inc, San Carlos, CA USA

[6] Univ Hosp Seidman Canc Ctr, Dept Internal Med, Cleveland, OH USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

721

引用

页数：1

共 50 条

[31] Serial circulating tumor DNA (ctDNA) monitoring to predict response to treatment in metastatic gastrointestinal cancers [J].

Parikh, A. ;

Kanter, K. ;

Mojtahed, A. ;

Schneider, J. ;

Van Seventer, E. ;

Fish, M. ;

Allen, J. ;

Blaszkowsky, L. ;

Wo, J. ;

Clark, J. ;

Giantonio, B. ;

Goyal, L. ;

Hong, T. ;

Nipp, R. ;

Roeland, E. ;

Weekes, C. ;

Zhu, A. ;

Ryan, D. ;

Fetter, I. ;

Horick, N. ;

Corcoran, R. .

ANNALS OF ONCOLOGY, 2019, 30

[32] Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade [J].

Lipson, Evan J. ;

Velculescu, Victor E. ;

Pritchard, Theresa S. ;

Sausen, Mark ;

Pardoll, Drew M. ;

Topalian, Suzanne L. ;

Diaz, Luis A., Jr. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2014, 2

[33] Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study [J].

Bergerot, Cristiane Decat ;

Philip, Errol J. ;

Govindarajan, Ameish ;

Castro, Daniela ;

Malhotra, Jasnoor ;

Bergerot, Paulo ;

Salgia, Sabrina ;

Salgia, Meghan ;

Salgia, Nicholas ;

Hsu, Joann ;

Meza, Luis ;

Zengin, Zeynep B. ;

Liu, Sandy ;

Chehrazi-Raffle, Alex ;

Tripathi, Abhishek ;

Dorff, Tanya ;

Pal, Sumanta .

CLINICAL GENITOURINARY CANCER, 2023, 21 (06) :626-+

[34] Efficacy of ramucirumab and docetaxel given either before or after immune checkpoint inhibitors in patients with lung cancers. [J].

Offin, Michael ;

Xu, Chongrui ;

Jain, Harsh ;

Makhnin, Alex ;

Hayes, Sara A. ;

Plodkowski, Andrew J. ;

Halpenny, Darragh ;

Rudin, Charles M. ;

Kris, Mark G. ;

Drilon, Alexander E. ;

Li, Bob T. ;

Paik, Paul K. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

[35] Tumor-informed assessment of circulating tumor DNA and its incorporation into practice for patients with hepatobiliary cancers. [J].

Kasi, Pashtoon Murtaza ;

Budde, Griffin ;

Dayyani, Farshid ;

Botta, Gregory P. ;

Diehl, Adam ;

King, Gentry Teng ;

Malla, Midhun ;

Abdelrahim, Maen ;

Hanna, Diana L. ;

Schafer, Liudmila N. ;

Tejani, Mohamedtaki Abdulaziz ;

Krainock, Michael ;

Billings, Paul R. ;

Olshan, Perry ;

Aushev, Vasily N. ;

Aleshin, Alexey .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

[36] Blood-based tumor mutational burden from circulating tumor DNA and immune checkpoint inhibitors in advanced prostate cancer. [J].

Rauterkus, Grant ;

Hadadi, Agreen ;

Barnett, Reagan ;

Weipert, Caroline ;

Drusbosky, Leylah ;

Gao, Xin ;

Lilly, Michael B. ;

Bryce, Alan Haruo ;

Naqvi, Syed Arsalan Ahmed ;

Barata, Pedro C. ;

Bilen, Mehmet Asim .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)

[37] Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors [J].

Seethapathy, Harish ;

Street, Sarah ;

Strohbehn, Ian ;

Lee, Meghan ;

Zhao, Sophia H. ;

Rusibamayila, Nifasha ;

Chute, Donald F. ;

Gao, Xin ;

Michaelson, Marc D. ;

Rahma, Osama E. ;

Choueiri, Toni K. ;

McGregor, Brad ;

Sonpavde, Guru ;

Salabao, Cristina ;

Kaymakcalan, Marina D. ;

Wei, Xiao ;

Gupta, Shruti ;

Motwani, Shveta ;

Leaf, David E. ;

Reynolds, Kerry L. ;

Sise, Meghan E. .

EUROPEAN JOURNAL OF CANCER, 2021, 157 :50-58

[38] The Role of Circulating Tumor DNA in Patients Treated with Adjuvant Immune Checkpoint Inhibitors: Clinical Reality or Distant Horizon? [J].

Maffezzoli, Michele ;

Nagpal, Ria ;

Elewaily, Mohamed ;

Pedapati, Lohitha ;

Samuel, Justin ;

Buti, Sebastiano ;

Malapelle, Umberto ;

Maniam, Akash ;

Banna, Giuseppe Luigi .

CURRENT ONCOLOGY REPORTS, 2025,

[39] Panel-derived TMB and immune-related GEP are associated with the response to immune checkpoint inhibitors (ICIs) in urothelial cancers. [J].

Tan, Kien Thiam ;

Chen, Shu-Jen ;

Hsieh, Yi-Lin ;

Su, Yu-Li ;

Jan, Yi-hua ;

Cheng, Jen Hao ;

Hsu, An ;

Huang, Wan-Ting ;

Zhuo, De-Wei ;

Wang, Woei-Fuh ;

Wei, Datsen George .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

[40] Circulating tumor DNA (ctDNA) informs clinical practice in patients with recurrent/ metastatic gastroesophageal cancers. [J].

Mehta, Rutika ;

Rivero-Hinojosa, Samuel ;

Dayyani, Farshid ;

Chao, Joseph ;

Carbonell, Jesus Izaguirre ;

Ferguson, Jenifer ;

Shariff, Bushra ;

Aushev, Vasily N. ;

Budde, Griffin ;

Sharma, Shruti ;

Malhotra, Meenakshi ;

Jurdi, Adham A. ;

Liu, Minetta C. ;

Klempner, Samuel J. ;

Huffman, Brandon .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 :427-427

← 1 2 3 4 5 →